- Advertisement -
The Therapeutic Goods Administration (TGA) has granted provisional approval for Novavax’s COVID-19 vaccine to be used in Australia.
The Novavax vaccine, branded as Nuvaxovid, has been approved for adults aged 18 years and over, and is administered over two doses delivered three weeks apart.
It is…

